The cyclooxygenase-2 inhibitor celecoxib effectively suppresses the development of non-melanoma skin cancers: results of a phase II/III clinical trial

被引：0
|
作者：
Elmets, C. A. [1 ]
Viner, J. L. [7 ]
Pentland, A. P. [9 ]
Cantrell, W. [1 ]
Bailey, H. [2 ]
Kang, S. [3 ]
Linden, K. G. [4 ]
Heffernan, M. [5 ]
Madeleine, D. [6 ]
Elewski, B. [1 ]
Umar, A. [7 ]
Lin, H. [1 ]
Bell, W. [1 ]
Gordon, G. [8 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Univ Wisconsin, Madison, WI USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Univ Calif Irvine, Irvine, CA USA
[5] Washington Univ, St Louis, MO USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] NCI, Bethesda, MD 20892 USA
[8] GD Searle Inc, Skokie, IL USA
[9] Univ Rochester, Rochester, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2009年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
325
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [11] Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases
    Cerchietti, LCA
    Bonomi, MR
    Navigante, AH
    Castro, MA
    Cabalar, ME
    Roth, BMC
    JOURNAL OF NEURO-ONCOLOGY, 2005, 71 (01) : 73 - 81
  • [12] Intratumoral administration of daromun in non-melanoma skin cancer: Preliminary results from a phase 2 non-randomized controlled trial
    Flatz, Lukas
    Wagner, Nikolaus B.
    Denisjuk, Natalja
    Do, Peter
    Nadal, Lisa
    Puca, Emanuele
    Elia, Giuliano
    Covelli, Alfredo
    Neri, Dario
    Cozzio, Antonio
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e147 - e149
  • [13] The cyclooxygenase-2 inhibitor rofecoxib (Vioxx®) in the treatment of cervical dysplasia grades II-III:: A phase II trial (vol 125, pg 251, 2006)
    Hefler, Lukas A.
    Grimm, Christoph
    Speiser, Paul
    Sliutz, Gerhard
    Reinthaller, Alexander
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 129 (01): : 100 - 100
  • [14] A randomized double-blind phase II evaluation of the cyclooxygenase-2 protein inhibitor celecoxib in treating severe dysplasia of the cervix.
    Farley, JH
    Truong, V
    McBroom, J
    Goo, E
    Larsen, W
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 480S - 480S
  • [15] RESULTS OF A PHASE II/III TRIAL OF CELECOXIB TO PREVENT RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER
    Lerner, Seth P.
    Lee, J. J.
    Liu, S.
    Grossman, H. Barton
    Czerniak, Bogden
    Richmond, E.
    Eagle, C.
    Lippman, Scott
    Sabichi, Anita L.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 71 - 71
  • [16] Phase I clinical trial using selective cyclooxygenase-2 (Cox-2) inhibitor celecoxib with concurrent thoracic irradiation in patients with poor prognosis non-small cell lung cancer (NSCLC)
    Liao, Z
    Komaki, R
    Milas, L
    Chen, Y
    Chang, JY
    Jeter, M
    Guerrero, T
    Craig, SW
    Blumenschien, G
    Smith, CM
    Cox, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S151 - S151
  • [17] Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer
    Gadgeel, Shirish M.
    Wozniak, Antoinette
    Ruckdeschel, John C.
    Heilbrun, Lance K.
    Venkatramanamoorthy, Raghu
    Chaplen, Ruth A.
    Kraut, Michael J.
    Kalemkerian, Gregory P.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (11) : 1293 - 1300
  • [18] Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature review
    Yokouchi, Hiroshi
    Kanazawa, Kenya
    Ishida, Takashi
    Oizumi, Satoshi
    Shinagawa, Naofumi
    Sukoh, Noriaki
    Harada, Masao
    Ogura, Shigeaki
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 744 - 750
  • [19] Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial
    Nugent, FW
    Mertens, WC
    Graziano, S
    Levitan, N
    Collea, R
    Gajra, A
    Marshall, J
    McCann, J
    LUNG CANCER, 2005, 48 (02) : 267 - 273
  • [20] A phase II clinical trial of celecoxib combined with platinum-based regimen as first-line chemotherapy for advanced non-small cell lung cancer patients with cyclooxygenase-2 positive expression
    Zhao, Jun
    Wang, Zhi-jie
    Duan, Jian-chun
    Guo, Qing-zhi
    Bai, Hua
    Yang, Lu
    An, Tong-tong
    Wang, Xin
    Wang, Yu-yan
    Wu, Mei-na
    Liu, Xu-yi
    Wang, Jie
    CHINESE JOURNAL OF CANCER RESEARCH, 2009, 21 (01) : 1 - 12
12345